SCHEMBL21395746

SCHEMBL21395746

N#Cc1ccc2oc3ccc(-c4ccc5cc(-c6ccc7ccc8cccnc8c7n6)ccc5c4)cc3c2c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP11B1 P15538 2/20 0.45
CYP11B2 P19099 2/20 0.45
CYP17A1 P05093 1/20 0.45
SLC40A1 Q9NP59 2/20 0.39
PGR P06401 2/20 0.38
CLK2 P49760 1/20 0.35
HIPK1 Q86Z02 1/20 0.35
DYRK2 Q92630 1/20 0.35
HIPK2 Q9H2X6 1/20 0.35
HIPK3 Q9H422 1/20 0.35
CLK4 Q9HAZ1 1/20 0.35
FABP1 P07148 1/20 0.35
PDE4A P27815 1/20 0.35
PDE4C Q08493 1/20 0.35
PDE4D Q08499 1/20 0.35
MAP3K14 Q99558 1/20 0.35
KDM4E B2RXH2 2/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
NEK1 Q96PY6 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21395739 0.97 SLC40A1 (0.41) CYP11B1CYP11B2CYP17A1SLC40A1PGR
SCHEMBL21395749 0.95 CYP17A1 (0.42) CYP11B1CYP11B2CYP17A1SLC40A1PGR
SCHEMBL21395744 0.94 CYP11B2 (0.41) CYP11B1CYP11B2CYP17A1SLC40A1PGR
SCHEMBL21395748 0.94 CYP11B2 (0.41) CYP11B1CYP11B2CYP17A1SLC40A1PGR
SCHEMBL20726732 0.89 SLC40A1 (0.39) CYP11B1CYP11B2CYP17A1SLC40A1PGR
SCHEMBL21395745 0.87 SLC40A1 (0.40) CYP11B1CYP11B2CYP17A1SLC40A1CLK2
SCHEMBL21396182 0.86 CYP11B1 (0.40) CYP11B1CYP11B2CYP17A1SLC40A1PGR
SCHEMBL21396183 0.86 PARP1 (0.40) CYP11B1CYP11B2CYP17A1SLC40A1PGR
SCHEMBL15581935 0.86 CCR1 (0.47) CLK2HIPK1DYRK2HIPK2HIPK3
SCHEMBL22064690 0.85 CYP11B2 (0.51) CYP11B1CYP11B2CYP17A1SLC40A1PGR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190292169-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2019-09-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190292169-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME LAGE3, PPOX, SUN2 CYP11B1 515/4885CYP11B2 183/4885CYP17A1 2548/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.